Clinical Trial Update: Prophylactic Inhaled Steroids to Reduce Radiation Pneumonitis Frequency and Severity in Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating prophylactic inhaled steroids to reduce the frequency and severity of radiation pneumonitis in patients with lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Radiation Pneumonitis

Drugs mentioned

• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Instituto Nacional de Cancerologia de Mexico | Conditions: Radiation Pneumonitis | Phase 2 | Status: RECRUITING